TG-1000

· TaiGen Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TG-1000, covering 2022-03-09 to 2022-03-09. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection [Phase 2]

See pricing